Physician profile
Adam Anton Sassoon
NPI 1750580882
$274,499.29
in general payments reported to CMS, 2019-2025
13 companies · $56K in 2025
The $56K reported for 2025 was more than what 89% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $46K · 2021: $40K · 2022: $24K · 2023: $53K · 2024: $7,345 · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $92K · Travel and Lodging: $10K · Food and Beverage: $7,511 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,863 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,522.97 |
| Travel and Lodging | $10,342.40 |
| Food and Beverage | $7,511.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,862.50 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $146,871.12 | 2019-2025 | Journey II, Real Intelligence, K-15 Pork |
| Biocomposites INC | $73,127.52 | 2019-2025 | Stimulan |
| Orthalign INC | $37,012.26 | 2019-2025 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $15,526.42 | 2019-2025 | Persona, Accufill, Ncb |
| Bone Support INC. | $1,000.00 | 2019 | |
| Overture Orthopaedics | $246.53 | 2025 | Overtureti |
| Depuy Synthes Sales INC. | $227.09 | 2023 | Attune |
| My01 INC. | $151.43 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Stryker Corporation | $144.73 | 2023 | Ezout |
| Uoc USA INC | $96.00 | 2021 | |
| Nuvasive, INC. | $39.77 | 2023 | Reline |
| Dynasplint Systems INC. | $34.83 | 2022-2023 | Dynasplint |
| Heron Therapeutics, INC. | $21.59 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$82,695.68 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Sassoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.